Delivery Order SPE2DR25D2013-SPE2DR26F5RCU
- Not listed
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,130.48 by the Defense Logistics Agency (DLA) on December 5, 2025, for the supply of Glimepiride 4 mg tablets (100-count units). This is a firm fixed price delivery order with an ultimate completion date of December 8, 2025, and represents a non-competitive, non-set-aside procurement. The award falls under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a $3,171.47 delivery order to AmerisourceBergen Drug Corp for 100 tablets of Glimepiride 4 mg on December 17, 2025, with an ultimate completion date of December 18, 2025. This competitively awarded, firm fixed price contract carries no set-aside designation and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $1,950.84 to AmerisourceBergen Drug Corp for the supply of Glimepiride 4 mg tablets in quantities of 100 units. This is a firm fixed-price, competitively awarded contract with an ultimate completion date of January 16, 2026. The contract has no set-aside designation and will be performed at the awardee's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $2,771.49 to AmerisourceBergen Drug Corp for the supply of Glimepiride 4 mg tablets (100-count packaging) under a firm fixed-price contract. The award, issued on December 5, 2025, with completion targeted for December 8, 2025, will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation, reflecting open competition among qualified...
- The Defense Logistics Agency awarded a delivery order valued at $10,454.95 to AmerisourceBergen Drug Corp for the supply of Glimepiride 4 mg tablets in quantities of 100 units. This is a firm fixed-price delivery order with an ultimate completion date of September 17, 2025, and no set-aside designation was applied. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its Corporate Office location. This award is...
- The Defense Logistics Agency awarded a delivery order valued at $5,577.55 to AmerisourceBergen Drug Corp for the supply of Glimepiride 4 mg tablets in quantities of 100, with an ultimate completion date of October 23, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed price terms and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's established role as a critical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp valued at $3,846.63 for Glimepiride 4 mg tablets (100-count units) on April 30, 2025, with an ultimate completion date of May 1, 2025. This competitively awarded contract utilizes firm fixed pricing with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $5,217.54 to AmerisourceBergen Drug Corp for the supply of Glimepiride 4 mg tablets (100-count units) with an ultimate completion date of June 2, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement...
- The Defense Logistics Agency awarded a delivery order valued at $2,174.34 to AmerisourceBergen Drug Corp for the supply of Glimepiride 4 mg tablets (100-count packaging) under a firm fixed-price contract. The award, issued on August 26, 2025, with an ultimate completion date of August 27, 2025, represents a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal healthcare vendor...
- The Defense Logistics Agency awarded a delivery order valued at $2,968.93 to AmerisourceBergen Drug Corp for the supply of Glimepiride 4 mg tablets (100-count units) under a firm fixed price contract. The award, issued on September 12, 2025, with an ultimate completion date of September 15, 2025, represents a non-set-aside competitive procurement. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the...
- SPE2DR25D2013Indefinite Delivery Contract
- SPE2DR25D2013-SPE2DR26F5RCUDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,606.91 to AmerisourceBergen Drug Corp for the supply of Glimepiride 4 mg tablets in quantities of 100 units. This competitively awarded, firm fixed-price contract has no set-aside designation and was executed on January 29, 2026, with an ultimate completion date of January 30, 2026. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026, which serves as the primary vehicle for supplying comprehensive pharmaceutical and medical supply needs to support military healthcare programs globally. AmerisourceBergen, a major pharmaceutical distributor and healthcare solutions provider, is a subsidiary of parent company Cencora, Inc., which also does business as AmerisourceBergen. The company serves as a critical vendor in the federal medical procurement supply chain, delivering a broad spectrum of pharmaceutical products across multiple therapeutic domains to military treatment facilities, veterans' healthcare programs, and other federal medical institutions. This delivery order for Glimepiride, a medication commonly used in diabetes management, reflects the company's ongoing role in fulfilling essential pharmaceutical needs for the Department of Defense's medical supply system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 1/28/26 |